The CD8+ T-cell clone NLV2, which was derived from a T1D patient as a control and recognises the HLA-A*0201-restricted HCMV pp65 epitope NLVPMVATV, displayed no direct lytic activity in the same assay. This evidence concerns the gene CD8A and type 1 diabetes mellitus.